Canbi  Pharma  Tech  Cyfyngedig
254740-64-2 sparsentan

254740-64-2 sparsentan

Enw'r Cynnyrch: SPARSENTAN
Cas: 254740-64-2
MF: C32H40N4O5S
MW: 592.75
Einecs:
MDL No.:MFCD16628036

Anfon ymchwiliad
Disgrifiad

Eiddo
Ymddangosiad gwyn i bowdr crisialog oddi ar wyn
Pwynt toddi: 148 gradd
Berwi: 744.4 ± 7 0. 0 gradd
Dwysedd 1.28 ± 0. 1 g\/cm3
Temp Storio. Storio ar radd -20
 

Cais:

Defnyddir sparsentan yn bennaf i drin neffrooglobwlin cynradd A nephropathi (IgAN) a glomerwlosclerosis cylchrannol ffocal cynradd (FSGS).

 

Cyfystyron:

splsentan

254740-64-2

esparsentan

splsentanum

(1,1'-biphenyl) -2- sulfonamide, 4 '-((2- butyl -4- oxo -1, 3- diazaspiro (4.4) non -1- en {-3- yl ) methyl) -n- (4, 5- dimethyl -3- isoxazolyl) -2 '-(ethoxymethyl)-

4'-((2-butyl-4-oxo-1,3-diazaspiro(4.4)non-1-en-3-yl)methyl)-N-(4,{{13 }} dimethyl -1, 2- oxazol -3- yl) -2 '-(ethoxymethyl) -2- biphenylfonamide

2- [{4- [(2- butyl -4- oxo -1, {3- diazaspiro [4.4] non -1-}}} YL) MET } (ethoxymethyl) phenyl] -n- (4, 5- dimethyl -1, 2- oxazol -3- yl) benzenesulfonamide

4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl)-N-(4,{{1 3}} dimethylisoxazol -3- yl) -2 '-(ethoxymethyl)-[1,1'-biphenyl] -2- sulfonamide

 

 

 

Tagiau poblogaidd: 254740-64-2 sparsentan, China 254740-64-2 Gwneuthurwyr Sparsentan, Cyflenwyr

Inquiry
goTop

(0/10)

clearall